- 全部删除
 
您的购物车当前为空
Anselamimab(安赛埃单抗)是一种人源化IgG1κ单克隆抗体,靶向血清淀粉样蛋白A1(SAA1)。它通过特异性结合淀粉样纤维,触发巨噬细胞和中性粒细胞的吞噬作用,从而清除淀粉样沉积物。Anselamimab在临床期中作为APP抑制剂((β-amyloid A4 Protein Precursor),用于治疗轻链(AL)淀粉样变性。

为众多的药物研发团队赋能,
让新药发现更简单!
Anselamimab(安赛埃单抗)是一种人源化IgG1κ单克隆抗体,靶向血清淀粉样蛋白A1(SAA1)。它通过特异性结合淀粉样纤维,触发巨噬细胞和中性粒细胞的吞噬作用,从而清除淀粉样沉积物。Anselamimab在临床期中作为APP抑制剂((β-amyloid A4 Protein Precursor),用于治疗轻链(AL)淀粉样变性。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,980  | In stock | |
| 5 mg | ¥ 4,970  | In stock | |
| 10 mg | ¥ 7,220  | In stock | |
| 25 mg | ¥ 10,700  | In stock | |
| 50 mg | ¥ 14,300  | In stock | 
| 产品描述 | Anselamimab is a humanized IgG1κ monoclonal antibody targeting serum amyloid A1 (SAA1). It removes amyloid deposits by specifically binding to amyloid fibrils and triggering phagocytosis by macrophages and neutrophils.Anselamimab was used as an APP(β-amyloid A4 Protein Precursor ) inhibitor  in the clinical phase for the treatment of light chain (AL) amyloidosis.  | 
| 别名 | 安赛埃单抗, CAEL-101, CAEL101 | 
| CAS No. | 2414866-63-8 | 
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容